awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47161820-0E846F3F-7A43-4C96-8376-DF7C1E0CA948
Q47161820-0E846F3F-7A43-4C96-8376-DF7C1E0CA948
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47161820-0E846F3F-7A43-4C96-8376-DF7C1E0CA948
Increasing AR by HIF-2α inhibitor (PT-2385) overcomes the side-effects of sorafenib by suppressing hepatocellular carcinoma invasion via alteration of pSTAT3, pAKT and pERK signals.
P2860
Q47161820-0E846F3F-7A43-4C96-8376-DF7C1E0CA948
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47161820-0E846F3F-7A43-4C96-8376-DF7C1E0CA948
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
81d12a43e02dde5277b9e8567a0a8b454be6364d
P2860
Sorafenib with ASC-J9® synergistically suppresses the HCC progression via altering the pSTAT3-CCL2/Bcl2 signals.